Hartwig Medical Foundation
To make the right treatment decision, cancer specialists need to collect all the available diagnostic information from the patient and their tumor.
We are contributing to this work by:
Developing
innovative molecular tests, for identifying the characteristics of the tumor.
Collecting and storing
knowledge of and information about the patient and their tumor.
Integrating
the information and knowledge with treatment outcome to accelerate scientific research. This enables us to learn from the data of today’s patients and provide better treatment for the patients of tomorrow.
Share your data
Your contribution to improving the treatment of tomorrow’s patients is important. Share your data, too!
Read moreShare your data and share our vision for the future of cancer diagnosis
Read the latest news
The Importance of Analyzing the DNA of Rare Tumors
One in four patients has a cancer type that is considered rare, meaning it occurs in fewer than six out …
To study rare cancers, collaboration is key
In honor of Rare Disease Day on February 28th, we spoke with Professor Stefan Fröhling about his research on rare …
Healthcare providers share insights about GENAYA for young adult cancer patients
In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …
Collaboration as the foundation for faster, better, and more affordable diagnostics
For Kees van den Berg, the CEO of GenomeScan, the collaboration between his organization and the Hartwig Medical Foundation is …
Predicting therapy success based on gene expression
In addition to Whole Genome Sequencing of DNA, Hartwig Medical Foundation performs Whole Transcriptome Sequencing of RNA. Researcher Marjolein Lansbergen …
Arno de Quaasteniet new member of the board of Hartwig Medical Foundation
Hartwig Medical Foundation is pleased to announce that as of October 1, 2024, Arno de Quaasteniet (1977) has been appointed …
Read the latest blogs
Cancer, a rare disease?
It may come as a surprise to many on this International Rare Disease Day (February 28), that a significant number …
Read more
The big advantage of having Hartwig Medical Foundation data available in the cloud
I don’t remember exactly when I first heard about Hartwig Medical Foundation and the whole genome sequencing data it has …
Read more
WGS is a helpful addition to our toolbox, alongside the classic HE, IHC and the (broad) NGS panels and should ideally be available in every regional oncology network